Related Experiment Video
Updated: May 24, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 is activated in response to disruption of the pre-mRNA splicing machinery
N Allende-Vega1, S Dayal, U Agarwala
1Division of Cancer Research, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Angus, UK.
Abstract:
In this study, we show that interfering with the splicing machinery results in activation of the tumour-suppressor p53. The spliceosome was targeted by small interfering RNA-mediated knockdown of proteins associated with different small nuclear ribonucleoprotein complexes and by using the small-molecule splicing modulator TG003. These interventions cause: the accumulation of p53, an increase in p53 transcriptional activity and can result in p53-dependent G(1) cell cycle arrest. Mdm2 and MdmX are two key repressors of p53. We show that a decrease in MdmX protein level contributes to p53 activation in response to targeting the spliceosome. Interfering with the spliceosome also causes an increase in the rate of degradation of Mdm2. Alterations in splicing are linked with tumour development. There are frequently global changes in splicing in cancer. Our study suggests that p53 activation could participate in protection against potential tumour-promoting defects in the spliceosome. A number of known p53-activating agents affect the splicing machinery and this could contribute to their ability to upregulate p53. Preclinical studies indicate that tumours can be more sensitive than normal cells to small-molecule spliceosome inhibitors. Activation of p53 could influence the selective anti-tumour activity of this therapeutic approach.
Insights
Targeting the spliceosome, the cell's splicing machinery, activates the tumor suppressor p53. This leads to cell cycle arrest and suggests a role for p53 in cancer protection and therapy.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- Alterations in RNA splicing are increasingly recognized as significant factors in tumor development.
- The spliceosome, a complex molecular machine, is crucial for RNA processing, and its dysregulation is common in cancer.
- The tumor suppressor p53 plays a critical role in cellular responses to stress and DNA damage.
Purpose of the Study:
- To investigate the consequences of interfering with the spliceosome on the activity of the tumor suppressor p53.
- To elucidate the mechanisms by which spliceosome modulation impacts p53 levels and function.
- To explore the potential implications of spliceosome-mediated p53 activation in cancer therapy.
Main Methods:
- Targeting the spliceosome using small interfering RNA (siRNA) to knock down associated proteins.
- Utilizing the small-molecule spliceosome modulator TG003.
- Assessing p53 accumulation, transcriptional activity, and p53-dependent cell cycle arrest.
- Analyzing the protein levels and degradation rates of p53 repressors Mdm2 and MdmX.
Main Results:
- Interference with the spliceosome machinery leads to the accumulation and activation of the tumor suppressor p53.
- p53 activation was characterized by increased transcriptional activity and p53-dependent G1 cell cycle arrest.
- Targeting the spliceosome resulted in decreased levels of MdmX and increased degradation of Mdm2, key p53 repressors.
- These findings suggest that p53 activation is a downstream consequence of spliceosome disruption.
Conclusions:
- Spliceosome integrity is critical for regulating p53 activity.
- p53 activation in response to spliceosome interference may serve as a protective mechanism against oncogenic splicing defects.
- The interplay between splicing, p53, and its repressors offers potential therapeutic strategies targeting cancer cells.
- Understanding how spliceosome inhibitors activate p53 could enhance their selective anti-tumor efficacy.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Splicing
RNA Splicing

